Watch Ticker

GT Biopharma Inc. Common Stock

Go to GT Biopharma Inc. Common Stock Website

$1.81

0.04 (2.26%)

Live

Previous Close

$1.77

Day Range

$1.72 - $1.8357

Previous Day Range

$1.72 - $1.78

Market Cap

$5.8 million USD

Day Vol.

15522

Previous Day Vol.

41526

Currency

USD

Primary Exchange

Nasdaq

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics f...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - GT Biopharma Announces Exercise of Warrants

GT Biopharma, a clinical-stage immuno-oncology company, announced it has entered into agreements for the exercise of existing warrants and the issuance of new warrants, raising approximately $0.7 million in gross proceeds.

Related tickers: GTBP.

Read Full Article

GT Biopharma, Inc. - GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia

SAN FRANCISCO, CALIFORNIA, June 27, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE® platform, today announced FDA clearance of its IND application for GTB-3650, allowing the company to proceed with a Phase 1 clinical trial, which is anticipated to start in second half of 2024.

Related tickers: GTBP.

Read Full Article

Trending Tickers

Please sign in to view